Clinical trials
Completed Multiple Endocrine Neoplasia Type 1 trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
75 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 8 |
| 2012 | 2 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 75 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Hospital for Sick Children | 5 |
| P.L.Shupik National Medical Academy of Post-Graduate Education | 3 |
| Arizona State University | 2 |
| Florida State University | 2 |
| Islamic Azad University, Sanandaj | 2 |
| Laval University | 2 |
| University of California, San Diego | 2 |
| University of Pennsylvania | 2 |
| Albert Einstein College of Medicine | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Endocrine Neoplasia Type 1 | 75 |
| Obesity | 14 |
| Overweight | 9 |
| Weight Loss | 9 |
| Acquired Immunodeficiency Syndrome | 4 |
| Cardiovascular Diseases | 3 |
| HIV Infections | 3 |
| Insulin Resistance | 3 |
| Osteoporosis | 3 |
| Sexually Transmitted Diseases | 3 |
Trials
Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.